2021
DOI: 10.1002/prca.202000058
|View full text |Cite
|
Sign up to set email alerts
|

Plasma nontargeted peptidomics discovers potential biomarkers for major depressive disorder

Abstract: Purpose There are great demands for identifying biomarkers of major depressive disorder (MDD), a common mental illness with a prevalence of approximately 6%. Finding potential biomarkers to aid MDD diagnosis is in high demand. Experimental Design In this study, a combination of pretreatment methods named salt‐out assisted liquid‐liquid extraction (SALLE) and nontargeted peptidomics based on nano‐LC‐Orbitrap/MS was primarily employed to discover the candidate peptide markers from the plasma of 238 subjects. Res… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 35 publications
(34 reference statements)
0
0
0
Order By: Relevance